Maximal Handgrip Strength as a Measure of General Functional Capacity Rather than Parkinson's Disease-Specific Impairment.
This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.
Bibliographic record from the original reports
Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.
Villamil-Cabello E, Molinero-Martín E, Fogelson N, Luque-Casado A, Fernández-Del-Olmo MÁ. Maximal Handgrip Strength as a Measure of General Functional Capacity Rather than Parkinson's Disease-Specific Impairment. Brain Sci. 2026;16(8):871. DOI 10.3390/brainsci16080871
Conditions: COND-PD Parkinson’s disease
Scoped audit evidence
These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.
Parkinson’s disease — strength
- access status: full_main_text_available
STR-08-02
STR-08-01
Limitations: Only current scoped checks; archived captures not authenticated against live originals.
Parkinson’s disease strength
- current access: full_main_text_available
- primary version: PMC full article; version not independently compared to publisher PDF
Parkinson’s disease strength component — Dominance/clinical-side contrasts and functional correlations
Results matches samples 45/51, more/less-affected force 213.68/232.33 N, difference −18.65 N and CI, d=.50, 22/23 dominance mapping, comparator-dependent significance, positive UPDRS rho=.34, and peak-force rather than RFD gait associations.
Source locator: Results Tables 2 and text around Figures 2–5
Limitations: AI-assisted source comparison; no raw-data verification.
Parkinson’s disease strength component — Custom-grip acquisition and strongest-trial RFD
Methods confirms standing extended-elbow testing, individualized handle, alternating two trials per hand, five-second efforts, 2-k Hz sampling, strongest-trial analysis and consecutive RFD windows. Numerical onset threshold and filtering remain unspecified.
Source locator: Methods 2.3
Limitations: AI-assisted source comparison; no raw-data verification.
Reports citing this source
- Strength muscle power and rapid force production assessment in Parkinson’s disease · reference 8 · original reference
Update record
- 2026-10-03: Created from the supplied reports and final scoped audit. New evidence should be appended with source version, access date, exact locator and affected report links.
Updating the wiki · Evidence and status guide